Kamada Ltd. Stock TEL AVIV STOCK EXCHANGE
Stocks
KMDA
IL0010941198
Pharmaceuticals
| Market Cap | 1.3B 434M 380M 350M 325M 618M 41.43B 626M 4.19B 1.63B 20.34B 1.63B 1.6B 70.51B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.3B 434M 380M 350M 325M 618M 41.43B 626M 4.19B 1.63B 20.34B 1.63B 1.6B 70.51B | EV / Sales 2026 * |
2.23x | EV / Sales 2027 * | 2.03x |
| Free-Float |
54.51% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Kamada Ltd.
| 1 day | +3.07% |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 57 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 55 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 53 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 64 | 24/12/2019 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.07% | +4.32% | - | - | 433M | |
| -0.68% | +2.85% | +20.76% | -7.81% | 66.56B | |
| -1.97% | -1.59% | +50.62% | +218.16% | 56.51B | |
| -1.13% | +40.50% | +40.50% | +40.50% | 42.98B | |
| +1.99% | +8.15% | -48.83% | -54.69% | 40.46B | |
| -3.54% | -3.77% | +60.19% | -26.85% | 31.91B | |
| +2.56% | +17.36% | +173.58% | -30.85% | 31.65B | |
| -1.06% | +0.84% | +71.87% | +83.93% | 23.35B | |
| +3.08% | +20.43% | +4.99% | +186.85% | 19.46B | |
| +0.21% | +2.96% | +66.67% | +129.01% | 17.18B | |
| Average | +0.17% | +9.08% | +48.93% | +59.81% | 36.67B | |
| Weighted average by Cap. | -0.49% | +7.69% | +43.45% | +52.46% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 585M 195M 171M 157M 146M 277M 18.61B 281M 1.88B 733M 9.14B 733M 717M 31.68B | 642M 214M 188M 173M 160M 305M 20.43B 309M 2.07B 805M 10.03B 804M 787M 34.78B |
| Net income | 72.01M 24.03M 21.05M 19.39M 17.99M 34.17M 2.29B 34.63M 232M 90.31M 1.13B 90.25M 88.27M 3.9B | 104M 34.59M 30.29M 27.9M 25.9M 49.18M 3.3B 49.85M 334M 130M 1.62B 130M 127M 5.62B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
